{
    "PMC": "5926936",
    "DOI": "10.1111/j.1349-7006.2002.tb01240.x",
    "PMID": "12495471",
    "PMCID": "PMC5926936",
    "title": "Differential mechanisms of constitutive Akt/PKB activation and its influence on gene expression in pancreatic cancer cells.",
    "year": 2002,
    "source_url": "https://europepmc.org/article/PMC/PMC5926936",
    "source": "MED",
    "abstract_text": "Activated Akt/protein kinase B transmits oncogenic signals leading to inhibition of apoptosis, cellular proliferation, and tolerance to hypoxia. Presently, mutational inactivation of PTEN and activation of Ras are considered to be the major causes of Akt activation. Here we report differential mechanisms of constitutive Akt activation in 4 human pancreatic cancer cell lines (KMP-3, KMP-4, PCI-66, and PCI-68). These 4 cell lines displayed phosphorylation and functional activation of Akt both in the presence and absence of serum, while three control cell lines (PCI-79, KMP-8, and PSN-1) did so only in the presence of serum in culture. All the 7 cell lines harbored K-Ras activated by mutations at codon 12 resulting in MAP kinase kinase (MEK1/2) phosphorylation, and all except one (KMP-8) had p53 mutations, indicating that these mutations are not sufficient for constitutive Akt activation. KMP-3 and KMP-4 had lost PTEN function owing to loss of expression or a mutation, but PCI-66 and PCI-68 retained wild-type PTEN. Phosphorylation of Akt was inhibited by the phosphatidylinositol-3-kinase (PI3K) inhibitor LY294002 and the tyrosine kinase inhibitor genistein in KMP-3 and KMP-4 cells, indicating that upstream signals are required for Akt activation in these two cell lines. In contrast, neither LY294002 nor genistein inhibited Akt activation in PCI-66 and PCI-68 cells, indicating the involvement of another unknown mechanism of Akt activation independent of PI3K-mediated signaling to Akt. Irrespective of the differential mechanisms, the 4 cell lines showed similar mRNA expression patterns of 49 genes assessed by cDNA array as compared to the 3 cell lines without Akt activation, suggesting that the mechanisms have the same consequences on the downstream signaling of the constitutive Akt activation.",
    "full_text": "Jpn J Cancer Res Jpn. J. Cancer Res 10.1111/(ISSN)1349-7006a CAS Japanese Journal of Cancer Research : Gann 0910-5050 1876-4673 Blackwell Publishing Ltd Oxford, UK 5926936 12495471 10.1111/j.1349-7006.2002.tb01240.x CAE1317 Article Differential Mechanisms of Constitutive Akt/PKB Activation and Its Influence on Gene Expression in Pancreatic Cancer Cells Matsumoto Joe 1 2 \u2020 Kaneda Masako 1 2 \u2020 Tada Mitsuhiro 1 Hamada Jun\u2010ichi 1 Okushiba Shunichi 2 Kondo Satoshi 2 Katoh Hiroyuki 2 Moriuchi Tetsuya 1 1 Division of Cancer\u2010related Genes, Institute for Genetic Medicine, Hokkaido University 2 Department of Surgical Oncology, Hokkaido University Graduate School of Medicine, N15 W7, Kita\u2010ku, Sapporo 060\u20100815 * To whom correspondence should be addressed. E\u2010mail: m_tada@med.hokudai.ac.jp \u2020 These two authors contributed equally to this study. 12 2002 93 12 10.1111/cas.2002.93.issue-12 1317 1326 Received June 28, 2002/Revised September 17, 2002/Accepted September 24, 2002 Activated Akt/protein kinase B transmits oncogenic signals leading to inhibition of apoptosis, cellular proliferation, and tolerance to hypoxia. Presently, mutational inactivation of PTEN and activation of Ras are considered to be the major causes of Akt activation. Here we report differential mechanisms of constitutive Akt activation in 4 human pancreatic cancer cell lines (KMP\u20103, KMP\u20104, PCI\u201066, and PCI\u201068). These 4 cell lines displayed phosphorylation and functional activation of Akt both in the presence and absence of serum, while three control cell lines (PCI\u201079, KMP\u20108, and PSN\u20101) did so only in the presence of serum in culture. All the 7 cell lines harbored K\u2010Ras activated by mutations at codon 12 resulting in MAP kinase kinase (MEK1/2) phosphorylation, and all except one (KMP\u20108) had p53 mutations, indicating that these mutations are not sufficient for constitutive Akt activation. KMP\u20103 and KMP\u20104 had lost PTEN function owing to loss of expression or a mutation, but PCI\u201066 and PCI\u201068 retained wild\u2010type PTEN. Phosphorylation of Akt was inhibited by the phosphatidylinositol\u20103\u2010kinase (PI3K) inhibitor LY294002 and the tyrosine kinase inhibitor genistein in KMP\u20103 and KMP\u20104 cells, indicating that upstream signals are required for Akt activation in these two cell lines. In contrast, neither LY294002 nor genistein inhibited Akt activation in PCI\u201066 and PCI\u201068 cells, indicating the involvement of another unknown mechanism of Akt activation independent of PI3K\u2010mediated signaling to Akt. Irrespective of the differential mechanisms, the 4 cell lines showed similar mRNA expression patterns of 49 genes assessed by cDNA array as compared to the 3 cell lines without Akt activation, suggesting that the mechanisms have the same consequences on the downstream signaling of the constitutive Akt activation. Pancreatic cancer Akt/protein kinase B Constitutive activation K\u2010ras PTEN source-schema-version-number 2.0 cover-date December 2002 details-of-publishers-convertor Converter:WILEY_ML3GV2_TO_NLMPMC version:4.6.9 mode:remove_FC converted:04.11.2015 REFERENCES 1 ) Datta , S. R. , Dudek , H. , Tao , X. , Masters , S. , Fu , H. , Gotoh , Y. and Greenberg , M. E. Akt phosphorylation of BAD couples survival signals to the cell\u2010intrinsic death machinery . Cell , 91 , 231 \u2013 241 ( 1997 ). 9346240 2 ) Romashkova , J. A. and Makarov , S. S. NF\u2010kappaB is a target of AKT in anti\u2010apoptotic PDGF signalling . Nature , 401 , 86 \u2013 90 ( 1999 ). 10485711 3 ) Brunei , A. , Bonni , A. , Zigmond , M. J. , Lin , M. Z. , Juo , P. , Hu , L. S. , Anderson , M. J. , Arden , K. C. , Blenis , J. and Greenberg , M. E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor . Cell , 96 , 857 \u2013 868 ( 1999 ). 10102273 4 ) Cardone , M. H. , Roy , N. , Stennicke , H. R. , Salvesen , G. S. , Franke , T. F. , Stanbridge , E. , Frisch , S. and Reed , J. C. Regulation of cell death protease caspase\u20109 by phosphorylation . Science , 282 , 1318 \u2013 1321 ( 1998 ). 9812896 5 ) Cheng , J. Q. , Altomare , D. A. , Klein , M. A. , Lee , W. C. , Kruh , G. D. , Lissy , N. A. and Testa , J. R. Transforming activity and mitosis\u2010related expression of the AKT2 oncogene: evidence suggesting a link between cell cycle regulation and oncogenesis . Oncogene , 14 , 2793 \u2013 2801 ( 1997 ). 9190895 6 ) Medema , R. H. , Kops , G. J. , Bos , J. L. and Burgering , B. M. AFX\u2010like Forkhead transcription factors mediate cell\u2010cycle regulation by Ras and PKB through p27kipl . Nature , 404 , 782 \u2013 787 ( 2000 ). 10783894 7 ) Zhong , H. , Chiles , K. , Feldser , D. , Laughner , E. , Hanrahan , C. , Georgescu , M. M. , Simons , J. W. and Semenza , G. L. Modulation of hypoxia\u2010inducible factor lalpha expression by the epidermal growth factor/phosphatidylinositol 3\u2010kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics . Cancer Res. , 60 , 1541 \u2013 1545 ( 2000 ). 10749120 8 ) Stambolic , V. , Suzuki , A. , Delapompa , J. L. , Brothers , G. M. , Mirtsos , C. , Sasaki , T. , Ruland , J. , Penninger , J. M. , Siderovski , D. P. and Mak , T. W. Negative regulation of PKB/Akt\u2010dependent cell survival by the tumor suppressor PTEN . Cell , 95 , 29 \u2013 39 ( 1998 ). 9778245 9 ) Otsu , M. , Hiles , L , Gout , L , Fry , M. J. , Ruiz\u2010Larrea , F. , Panayotou , G. , Thompson , A. , Dhand , R. , Hsuan , J. , Totty , N. , Courtneidge , S. and Waterfield , M. Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle\u2010T/pp60c\u2010src complexes, and PI3\u2010kinase . Cell , 65 , 91 \u2013 104 ( 1991 ). 1707345 10 ) Rodriguez\u2010Viciana , P. , Warne , P. H. , Dhand , R. , Vanhaesebroeck , B. , Gout , I. , Fry , M. J. , Waterfield , M. D. and Downward , J. Phosphatidylinositol\u20103\u2010OH kinase as a direct target of Ras . Nature , 370 , 527 \u2013 532 ( 1994 ). 8052307 11 ) Myers , M. P. , Pass , I. , Batty , I. H. , Van der Kaay , J. , Stolarov , J. P. , Hemmings , B. A. , Wigler , M. H. , Downes , C. P. and Tonks , N. K. The lipid phosphatase activity of PTEN is critical for its tumor suppressor function . Proc. Natl. Acad. Sci. USA , 95 , 13513 \u2013 13518 ( 1998 ). 9811831 12 ) Haas\u2010Kogan , D. , Shalev , N. , Wong , M. , Mills , G. , Yount , G. and Stokoe , D. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC . Curr. Biol. , 8 , 1195 \u2013 1198 ( 1998 ). 9799739 13 ) Zhang , C. L. , Tada , M. , Kobayashi , H. , Nozaki , M. , Moriuchi , T. and Abe , H. Detection of PTEN nonsense mutation and psiPTEN expression in central nervous system high\u2010grade astrocytic tumors by a yeast\u2010based stop codon assay . Oncogene , 19 , 4346 \u2013 4353 ( 2000 ). 10980610 14 ) Tashiro , H. , Blazes , M. S. , Wu , R. , Cho , K. R. , Bose , S. , Wang , S. I. , Li , J. , Parsons , R. and Ellenson , L. H. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies . Cancer Res. , 57 , 3935 \u2013 3940 ( 1997 ). 9307275 15 ) Tsao , H. , Zhang , X. , Fowlkes , K. and Haluska , F. G. Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines . Cancer Res. , 60 , 1800 \u2013 1804 ( 2000 ). 10766161 16 ) Dahia , P. L. , Marsh , D. J. , Zheng , Z. , Zedenius , J. , Komminoth , P. , Frisk , T. , Wallin , G. , Parsons , R. , Longy , M. , Larsson , C. and Eng , C. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors . Cancer Res. , 57 , 4710 \u2013 4713 ( 1997 ). 9354427 17 ) Ruggeri , B. A. , Huang , L. , Wood , M. , Cheng , J. Q. and Testa , J. R. Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas . Mol. Carcinog. , 21 , 81 \u2013 86 ( 1998 ). 9496907 18 ) Hu , Q. , Klippel , A. , Muslin , A. J. , Fantl , W. J. and Williams , L. T. Ras\u2010dependent induction of cellular responses by constitutively active phosphatidylinositol\u20103 kinase . Science , 268 , 100 \u2013 102 ( 1995 ). 7701328 19 ) Marte , B. M. , Rodriguez\u2010Viciana , P. , Wennstrom , S. , Warne , P. H. and Downward , J. R\u2010Ras can activate the phosphoinositide 3\u2010kinase but not the MAP kinase arm of the Ras effector pathways . Curr. Biol. , 7 , 63 \u2013 70 ( 1997 ). 8999998 20 ) Tolias , K. F. , Cantley , L. C. and Carpenter , C. L. Rho family GTPases bind to phosphoinositide kinases . J. Biol. Chem. , 270 , 17656 \u2013 17659 ( 1995 ). 7629060 21 ) Lee , S. W. , Fang , L. , Igarashi , M. , Ouchi , T. , Lu , K. P. and Aaronson , S. A. Sustained activation of Ras/Raf/mitogen\u2010activated protein kinase cascade by the tumor suppressor p53 . Proc. Natl. Acad. Sci. USA , 97 , 8302 \u2013 8305 ( 2000 ). 10890907 22 ) Fang , L. , Li , G. , Liu , G. , Lee , S. W. and Aaronson , S. A. p53 induction of heparin\u2010binding EGF\u2010like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades . EMBO J. , 20 , 1931 \u2013 1939 ( 2001 ). 11296226 23 ) Flaman , J.\u2010M. , Frebourg , T. , Moreau , V. , Charbonnier , F. , Martin , C. , Chappuis , P. , Sappino , A.\u2010P. , Limacher , J.\u2010M. , Brons , L. , Benhattar , J. , Tada , M. , Van Meir , E. G. , Estreicher , A. and Iggo , R. D. A simple p53 functional assay for screening cell lines, blood, and tumors . Proc. Natl. Acad. Sci. USA , 92 , 3963 \u2013 3967 ( 1995 ). 7732013 24 ) Kashiwazaki , H. , Tonoki , H. , Tada , M. , Chiba , L , Shindoh , M. , Totsuka , Y. , Iggo , R. and Moriuchi , T. High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay . Oncogene , 15 , 2667 \u2013 2674 ( 1997 ). 9400993 25 ) Cheng , J. Q. , Ruggeri , B. , Klein , W. M. , Sonoda , G. , Altomare , D. A. , Watson , D. K. and Testa , J. R. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA . Proc. Natl. Acad. Sci. USA , 93 , 3636 \u2013 3641 ( 1996 ). 8622988 26 ) Gire , V. , Marshall , C. and Wynford\u2010Thomas , D. PI\u20103\u2010kinase is an essential anti\u2010apoptotic effector in the proliferative response of primary human epithelial cells to mutant RAS . Oncogene , 19 , 2269 \u2013 2276 ( 2000 ). 10822377 27 ) Moodie , S. A. and Wolfman , A. The 3Rs of life: Ras, Raf and growth regulation . Trends Genet , 10 , 44 \u2013 48 ( 1994 ). 8191584 28 ) Vlahos , C. J. , Matter , W. F. , Hui , K. Y. and Brown , R. F. A specific inhibitor of phosphatidylinositol 3\u2010kinase, 2\u2010(4\u2010morpholinyl)\u20108\u2010phenyl\u20104H\u2010l\u2010benzopyran\u20104\u2010one (LY294002) . J. Biol. Chem. , 269 , 5241 \u2013 5248 ( 1994 ). 8106507 29 ) Lemoine , N. R. , Hughes , C. M. , Barton , C. M. , Poulsom , R. , Jeffery , R. E. , Kloppel , G. , Hall , P. A. and Gullick , W. J. The epidermal growth factor receptor in human pancreatic cancer . J. Pathol. , 166 , 7 \u2013 12 ( 1992 ). 1538276 30 ) Barton , C. M. , Hall , P. A. , Hughes , C. M. , Gullick , W. J. and Lemoine , N. R. Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer . J. Pathol. , 163 , 111 \u2013 116 ( 1991 ). 1707959 31 ) Akiyama , T. , Ishida , J. , Nakagawa , S. , Ogawara , H. , Watanabe , S. , Itoh , N. , Shibuya , M. and Fukami , Y. Genistein, a specific inhibitor of tyrosine\u2010specific protein kinases . J. Biol. Chem. , 262 , 5592 \u2013 5595 ( 1987 ). 3106339 32 ) Alessi , D. R. , Andjelkovic , M. , Caudwell , B. , Cron , P. , Morrice , N. , Cohen , P. and Hemmings , B. A. Mechanism of activation of protein kinase B by insulin and IGF\u20101 . EMBO J. , 15 , 6541 \u2013 6551 ( 1996 ). 8978681 33 ) Bellacosa , A. , Chan , T. O. , Ahmed , N. N. , Datta , K. , Malstrom , S. , Stokoe , D. , McCormick , F. , Feng , J. and Tsichlis , P. Akt activation by growth factors is a multiple\u2010step process: the role of the PH domain . Oncogene , 17 , 313 \u2013 325 ( 1998 ). 9690513 34 ) Yip\u2010Schneider , M. T. , Lin , A. and Marshall , M. S. Pancreatic tumor cells with mutant K\u2010ras suppress ERK activity by MEK\u2010dependent induction of MAP kinase phosphatase\u20102 . Biochem. Biophys. Res. Commun. , 280 , 992 \u2013 997 ( 2001 ). 11162624 35 ) Holland , E. C. , Celestino , J. , Dai , C. , Schaefer , L. , Sawaya , R. E. and Fuller , G. N. Combined activation of ras and akt in neural progenitors induces glioblastoma formation in mice . Nat. Genet. , 25 , 55 \u2013 57 ( 2000 ). 10802656 36 ) Tolkacheva , T. and Chan , A. M. Inhibition of H\u2010Ras transformation by the PTEN/MMAC1/TEP1 tumor suppressor gene . Oncogene , 19 , 680 \u2013 689 ( 2000 ). 10698513 37 ) Yan , J. , Roy , S. , Apolloni , A. , Lane , A. and Hancock , J. F. Ras isoforms vary in their ability to activate Raf\u20101 and phosphoinositide 3\u2010kinase . J. Biol. Chem. , 273 , 24052 \u2013 24056 ( 1998 ). 9727023 38 ) Bos , J. L. ras oncogenes in human cancer: a review . Cancer Res. , 49 , 4682 \u2013 4689 ( 1989 ). 2547513 39 ) Przybojewska , B. , Jagiello , A. and Jalmuzna , P. H\u2010RAS, K\u2010RAS, and N\u2010RAS gene activation in human bladder cancers . Cancer Genet. Cytogenet. , 121 , 73 \u2013 77 ( 2000 ). 10958945 40 ) Nguyen , K. T. , Wang , W. J. , Chan , J. L. and Wang , L. H. Differential requirements of the MAP kinase and PIS kinase signaling pathways in Src\u2010 versus insulin and IGF\u20101 receptors\u2010induced growth and transformation of rat intestinal epithelial cells . Oncogene , 19 , 5385 \u2013 5397 ( 2000 ). 11103940 41 ) Penuel , E. and Martin , G. S. Transformation by v\u2010Src: Ras\u2010MAPK and PI3K\u2010mTOR mediate parallel pathways . Mol. Biol. Cell , 10 , 1693 \u2013 1703 ( 1999 ). 10359590 42 ) Zimmermann , S. and Moelling , K. Phosphorylation and regulation of Raf by Akt (protein kinase B) . Science , 286 , 1741 \u2013 1744 ( 1999 ). 10576742 43 ) Kauffmann\u2010Zeh , A. , Rodriguez\u2010Viciana , P. , Ulrich , E. , Gilbert , C. , Coffer , P. , Downward , J. and Evan , G. Suppression of c\u2010Myc\u2010induced apoptosis by Ras signaling through PI(3)K and PKB . Nature , 385 , 544 \u2013 548 ( 1997 ). 9020362 44 ) Wick , M. J. , Dong , L. Q. , Riojas , R. A. , Ramos , F. J. and Liu , F. Mechanism of phosphorylation of protein kinase B/Akt by a constitutively active 3\u2010phosphoinositide\u2010dependent protein kinase\u20101 . J. Biol. Chem. , 275 , 40400 \u2013 40406 ( 2000 ). 11006271 45 ) Shao , J. , Sheng , H. and DuBois , R. N. Peroxisome proliferator\u2010activated receptors modulate K\u2010Ras\u2010mediated transformation of intestinal epithelial cells . Cancer Res. , 62 , 3282 \u2013 3288 ( 2002 ). 12036946 46 ) Hock , B. , Bohme , B. , Karn , T. , Yamamoto , T. , Kaibuchi , K. , Holtrich , U. , Holland , S. , Pawson , T. , Rubsamen\u2010Waigmann , H. and Strebhardt , K. PDZ\u2010domain\u2010mediated interaction of the Eph\u2010related receptor tyrosine kinase EphB3 and the ras\u2010binding protein AF6 depends on the kinase activity of the receptor . Proc. Natl. Acad. Sci. USA , 95 , 9779 \u2013 9784 ( 1998 ). 9707552 47 ) Clark , G. J. , Kinch , M. S. , Rogers\u2010Graham , K. , Sebti , S. M. , Hamilton , A. D. and Der , C. J. The Ras\u2010related protein Rheb is farnesylated and antagonizes Ras signaling and transformation . J. Biol. Chem. , 272 , 10608 \u2013 10615 ( 1997 ). 9099708 48 ) Du , K. and Montminy , M. CREB is a regulatory target for the protein kinase Akt/PKB . J. Biol. Chem. , 273 , 32377 \u2013 32379 ( 1998 ). 9829964 49 ) Miknyoczki , S. J. , Lang , D. , Huang , L. , Klein\u2010Szanto , A. J. , Dionne , C. A. and Ruggeri , B. A. Neurotrophins and Trk receptors in human pancreatic ductal adenocarcinoma: expression patterns and effects on in vitro invasive behavior . Int. J. Cancer , 81 , 417 \u2013 427 ( 1999 ). 10209957 50 ) Qian , X. , Esteban , L. , Vass , W. C. , Upadhyaya , C. , Papageorge , A. G. , Yienger , K. , Ward , J. M. , Lowy , D. R. and Santos , E. The Sos1 and Sos2 Ras\u2010specific exchange factors: differences in placental expression and signaling properties . EMBO J. , 19 , 642 \u2013 654 ( 2000 ). 10675333 51 ) de Kok , A. J. , Sips , H. , Chang , G. T. and Verheijen , J. H. Enhanced plasminogen activator production of Syrian hamster embryo cells transformed by chemicals or the c\u2010Ha\u2010ras oncogene: type of plasminogen activators involved and their contribution to the transformed phenotype . Carcinogenesis , 10 , 1155 \u2013 1161 ( 1989 ). 2500266 52 ) Diaz\u2010Meco , M. T. , Quinones , S. , Municio , M. M. , Sanz , L. , Bernal , D. , Cabrero , E. , Saus , J. and Moscat , J. Protein kinase C\u2010independent expression of stromelysin by platelet\u2010derived growth factor, ras oncogene, and phosphatidylcholine\u2010hydrolyzing phospholipase C . J. Biol. Chem. , 266 , 22597 \u2013 22602 ( 1991 ). 1718997 53 ) Gum , R. , Lengyel , E. , Juarez , J. , Chen , J. H. , Sato , H. , Seiki , M. and Boyd , D. Stimulation of 92\u2010kDa gelatinase B promoter activity by ras is mitogen\u2010activated protein kinase kinase 1\u2010independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP\u20101 sequences . J. Biol. Chem. , 271 , 10672 \u2013 10680 ( 1996 ). 8631874 54 ) Hurta , R. A. and Wright , J. A. Alterations in the cyclic AMP signal transduction pathway regulating ribonucleotide reductase gene expression in malignant H\u2010ras transformed cell lines . J. Cell. Physiol. , 158 , 187 \u2013 197 ( 1994 ). 7505277 55 ) Futakawa , N. , Kimura , W. , Yamagata , S. , Zhao , B. , Ilsoo , H. , Inoue , T. , Sata , N. , Kawaguchi , Y. , Kubota , Y. and Muto , T. Significance of K\u2010ras mutation and CEA level in pancreatic juice in the diagnosis of pancreatic cancer . J. Hepatobiliary Pancreat. Surg. , 7 , 63 \u2013 71 ( 2000 ). 10982594 56 ) Sorio , C. , Baron , A. , Orlandini , S. , Zamboni , G. , Pederzoli , P. , Huebner , K. and Scarpa , A. The FHIT gene is expressed in pancreatic ductular cells and is altered in pancreatic cancers . Cancer Res. , 59 , 1308 \u2013 1314 ( 1999 ). 10096564 57 ) Mandriota , S. J. , Jussila , L. , Jeltsch , M. , Compagni , A. , Baetens , D. , Prevo , R. , Banerji , S. , Huarte , J. , Montesano , R. , Jackson , D. G. , Orci , L. , Alitalo , K. , Christofori , G. and Pepper , M. S. Vascular endothelial growth factor\u2010C\u2010mediated lymphangiogenesis promotes tumour metastasis . EMBO J. , 20 , 672 \u2013 682 ( 2001 ). 11179212 58 ) Shimoyama , S. , Gansauge , F. , Gansauge , S. , Widmaier , U. , Oohara , T. and Beger , H. G. Overexpression of intercellular adhesion molecule\u20101 (ICAM\u20101) in pancreatic adenocarcinoma in comparison with normal pancreas . Pancreas , 14 , 181 \u2013 186 ( 1997 ). 9057191 59 ) Kamohara , H. , Sakamoto , K. , Ishiko , T. , Mita , S. , Masuda , Y. , Abe , T. and Ogawa , M. Human carcinoma cell lines produce biologically active leukemia inhibitory factor (LIF) . Res. Commun. Mol. Pathol. Pharmacol. , 85 , 131 \u2013 140 ( 1994 ). 7994557 60 ) Ohba , Y. , Mochizuki , N. , Yamashita , S. , Chan , A. M. , Schrader , J. W. , Hattori , S. , Nagashima , K. and Matsuda , M. Regulatory proteins of R\u2010Ras, TC21/R\u2010Ras2, and M\u2010Ras/R\u2010Ras3 . J. Biol. Chem. , 275 , 20020 \u2013 20026 ( 2000 ). 10777492 61 ) Beguinot , L. , Werth , D. , Ito , S. , Richert , N. , Willingham , M. C. and Pastan , I. Functional studies on the EOF receptor with an antibody that recognizes the intracellular portion of the receptor . J. Biol. Chem. , 261 , 1801 \u2013 1807 ( 1986 ). 2418017",
    "full_text_abstract": "Activated Akt/protein kinase B transmits oncogenic signals leading to inhibition of apoptosis, cellular proliferation, and tolerance to hypoxia. Presently, mutational inactivation of PTEN and activation of Ras are considered to be the major causes of Akt activation. Here we report differential mechanisms of constitutive Akt activation in 4 human pancreatic cancer cell lines (KMP\u20103, KMP\u20104, PCI\u201066, and PCI\u201068). These 4 cell lines displayed phosphorylation and functional activation of Akt both in the presence and absence of serum, while three control cell lines (PCI\u201079, KMP\u20108, and PSN\u20101) did so only in the presence of serum in culture. All the 7 cell lines harbored K\u2010Ras activated by mutations at codon 12 resulting in MAP kinase kinase (MEK1/2) phosphorylation, and all except one (KMP\u20108) had p53 mutations, indicating that these mutations are not sufficient for constitutive Akt activation. KMP\u20103 and KMP\u20104 had lost PTEN function owing to loss of expression or a mutation, but PCI\u201066 and PCI\u201068 retained wild\u2010type PTEN. Phosphorylation of Akt was inhibited by the phosphatidylinositol\u20103\u2010kinase (PI3K) inhibitor LY294002 and the tyrosine kinase inhibitor genistein in KMP\u20103 and KMP\u20104 cells, indicating that upstream signals are required for Akt activation in these two cell lines. In contrast, neither LY294002 nor genistein inhibited Akt activation in PCI\u201066 and PCI\u201068 cells, indicating the involvement of another unknown mechanism of Akt activation independent of PI3K\u2010mediated signaling to Akt. Irrespective of the differential mechanisms, the 4 cell lines showed similar mRNA expression patterns of 49 genes assessed by cDNA array as compared to the 3 cell lines without Akt activation, suggesting that the mechanisms have the same consequences on the downstream signaling of the constitutive Akt activation."
}